Losses widen but strategic refocus will deliver cost savings

Losses widen but strategic refocus will deliver cost savings

Drug development company Redx Pharma has seen its half year losses widen to £10.7m but says a strategic refocus of the business is expected to deliver annual cost savings of almost half that amount in the future. The company, which is moved its headquarters from Liverpool to Alderley Park in Cheshire towards the end of last year, saw its losses increase from £7.1m for the same period last year. In March Redx announced it was cutting staff numbers by 60%, following a change in strategy to focus more on pipeline development than…

See the article in full at TheBusinessDesk.com

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.